Our observation is concordant with the enhanced IFN-γ production by lymphocytes reported in ex vivo studies using rhIL-7 for immunosuppressed patients with septic shock (18, 44, 45) and, more recently, also for patients with critically ill COVID-19 (17, 19). The gene discussed is IFNG; the disease is COVID-19.